Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,701 - 1,720 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((greatest decrease) OR (a decrease)) ))', query time: 0.57s Refine Results
  1. 1701
    <i>SLC2A2</i> is essential for liver differentiation in developing vertebrates

    <i>SLC2A2</i> is essential for liver differentiation in developing vertebrates by Yejin Kim (740789)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1702
    Primers used for qPCR gene expression analysis.

    Primers used for qPCR gene expression analysis. by Yejin Kim (740789)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1703
    The IGF1R pathway is upregulated following <i>slc2a2</i> knockdown in HepG2 cells and zebrafish embryos.

    The IGF1R pathway is upregulated following <i>slc2a2</i> knockdown in HepG2 cells and zebrafish embryos. by Yejin Kim (740789)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1704
    Gene expression dynamics during liver development.

    Gene expression dynamics during liver development. by Yejin Kim (740789)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1705
    Protein levels of GLUT2 were analyzed by western blotting.

    Protein levels of GLUT2 were analyzed by western blotting. by Yejin Kim (740789)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1706
    Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs.

    Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 1707
    Oligonucleotides used in this study.

    Oligonucleotides used in this study. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 1708
    Data supporting the findings of this study.

    Data supporting the findings of this study. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 1709
    Impact of 5′ nucleotidase disruption on <i>M</i>. <i>bovis</i> growth phenotype in axenic conditions.

    Impact of 5′ nucleotidase disruption on <i>M</i>. <i>bovis</i> growth phenotype in axenic conditions. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 1710
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1711
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1712
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1713
    <i>M</i>. <i>bovis</i> 0690::Tn mutant failed to elicit the recruitment of neutrophils into milk spaces.

    <i>M</i>. <i>bovis</i> 0690::Tn mutant failed to elicit the recruitment of neutrophils into milk spaces. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 1714
    Loss of mammary fitness and virulence by <i>M</i>. <i>bovis</i> 0690::Tn mutant.

    Loss of mammary fitness and virulence by <i>M</i>. <i>bovis</i> 0690::Tn mutant. by Aga E. Gelgie (17661720)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1715
    Open data.

    Open data. by Larissa Brazolotto Ferreira (17671168)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1716
    I Optimal design for optimization of Axitinib loaded Spanlastics.

    I Optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1717
    ANOVA for I optimal design of Axitinib loaded Spanlastics.

    ANOVA for I optimal design of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1718
    The kinetic release data of the optimized formula compared to drug suspension.

    The kinetic release data of the optimized formula compared to drug suspension. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1719
    Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics.

    Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1720
    The composition and validation of the optimized formula with its predicted responses according to I Optimal Design.

    The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. by Randa Mohammed Zaki (21637175)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: